High intravascular tissue factor-but not extracellular microvesicles-in septic patients is associated with a high

Carolin Trepesch1, Ramona Nitzsche1, Aenne Glass2

  • 1Institute of Medical Microbiology, Virology and Hygiene, Rostock University Medical Center, Schillingallee 70, 18057 Rostock, Germany.

Abstract

Insights

High levels of tissue factor (TF) in sepsis patients correlate with increased disease severity and mortality risk. Conversely, microvesicles (MVs) may indicate a better prognosis in sepsis patients.

Area of Science:

  • Coagulation and Thrombosis Research
  • Critical Care Medicine
  • Sepsis Pathophysiology

Background:

  • Sepsis often involves coagulation abnormalities, with intravascular tissue factor (TF) potentially driving organ failure.
  • Circulating microvesicles (MVs) increase during sepsis; their role in host response and complications remains unclear.

Purpose of the Study:

  • To investigate the association between plasma TF, MVs, and the risk of multiple organ failure and mortality in sepsis patients.

Main Methods:

  • Prospective pilot study of 30 sepsis patients (19 survivors, 11 non-survivors).
  • Plasma samples collected daily for up to 2 weeks.
  • Quantification of TF and MVs using ELISA.

Main Results:

  • Non-survivors exhibited significantly higher TF concentrations on day 3 compared to survivors.
  • High TF levels were associated with increased disease severity (high SAPS II scores; OR 18.7).
  • Higher phosphatidylserine-rich MVs showed a trend towards lower mortality and organ failure risk, though not statistically significant.

Conclusions:

  • Elevated TF in sepsis patients is significantly linked to increased disease severity (high SAPS II score).
  • Quantifying total MVs in plasma may serve as an indicator of patient outcomes in sepsis.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.0K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
655
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
714
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
422
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
8.9K